• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Supernus Pharmaceuticals, Inc. (SUPN)

    -NGM
    11.78 Up 0.46(4.06%) Mar 27, 4:00PM EDT
    |After Hours : 11.78 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Net Income 4,355   27,858   3,201   (15,543)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation718  753  746  801  
    Adjustments To Net Income(120)768  13  1,684  
    Changes In Accounts Receivables(1,957)(4,446)(989)(4,824)
    Changes In Liabilities6,192  3,134  (7,268)90  
    Changes In Inventories(2,296)(1,044)(2,144)(805)
    Changes In Other Operating Activities102  (240)(499)(507)
    Total Cash Flow From Operating Activities 6,994   26,783   (6,940) (19,104)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(118)(94)(118)(263)
    Investments(7,210)230  7,501  (310)
    Other Cash flows from Investing Activities(1,356)(1,109)(984)(1,056)
    Total Cash Flows From Investing Activities (8,684) (973) 6,399   (1,629)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock306  14  245  5  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities 306   14   245   5  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (1,384) 25,824   (296) (20,728)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.